Presentations by FDA scientists on Alternative Methods
List of FDA scientists presentations on alternative methods
FDA scientists from across the agency have given presentations on topics related to advancing alternative methods. The list below is current and updated regularly.
Presentations
Advancing New Alternative Methods at FDA, given by Donna L. Mendrick, PhD
at the MPS World Summit 2023 on June 27, 2023
New Approach Methodologies for Use in FDA Food Safety Assessments, given by Suzanne Fitzpatrick, PhD, DABT, ERT
at the ICCVAM Public Meeting on May 18, 2023
Perspectives on Evaluating New Tools for Regulatory Use, given by Donna L. Mendrick, PhD
at the DIA 2022 session: The Translational Value of Animal Models in Rare Diseases on June 20, 2022
Advancing Alternative Methods for Regulatory Use, given by David Strauss, MD, PhD
at the FDA Science Board on June 14, 2022
Advancing Alternatives at FDA, given by Donna L. Mendrick, Ph.D.
at the IUTOX panel discussion at the Society of Toxicology Annual Meeting on March 16, 2021
FDA, ICH, and the 3Rs, September 2020
Microphysiological Systems to Assess the Functional Capacity of Cellular Therapy Products
Predicting the Effects of Candidate Drugs: The Future, given by Janet Woodcock, M.D.
Nov. 18, 2020 at the American College of Toxicology Annual Meeting
Resources for You
Advancing Alternative Methods at FDA
FDA's Predictive Toxicology Roadmap